Aspergillosis: Diagnosis and treatment

International Journal of Antimicrobial Agents

Volumn 6, Issue 3, 1996, Pages 161-168

  Denning, David W ^a,b  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aspergillosis; Diagnosis; Treatment

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTICOSTEROID; ITRACONAZOLE; LIPOSOME;

ANEMIA; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BRONCHOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; MORBIDITY; MORTALITY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SPUTUM CULTURE; TREATMENT FAILURE;

EID: 0029866927     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(95)00042-9     Document Type: Conference Paper

References (37)

1. Bodey G, Bueltmann B, Duguid W et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
2. Groll A, Shah PM, Mentzel CH, Schneider M. Changing pattern of invasive mycoses at autopsy. Abstract J109, Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL. American Society for Microbiology, October 1994.
3. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345-351.
4. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989;114:555-560.
5. Khoo S, Denning DW. Aspergillus infection in the acquired immune deficiency syndrome. Clin Infect Dis 1994;19(suppl 1):541-548.
6. McWhinney PHM, Kibbler CC, Hamon MD et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: thirteen years experience. Clin Infect Dis 1993;17:397-404.
7. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH. Invasive aspergillosis in renal transplant recipients. Correlation with corticosteroid therapy. J Infect Dis 1983;148:230-234.
8. Martino P, Raccah R, Gentile G et al. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Haematologica 1989;74:263-265.
9. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982;69:617-631.
10. Roilides E, Unlig K, Venzon D, Pizza PA, Walsh TJ. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993;61:4870-4877.
11. Ng TTC, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994;140:2475-2480.
12. Midiri M, Lo Casto A, Cascio A, Scarlata F, De Maria M. Invasive pulmonary aspergillosis: CT findings. Med J Infect Parasit Dis 1994;IX:59-62.
13. Taccone A, Occhi M, Garaventa A, Manfredini L, Viscoli C. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 1993;23:177-180.
14. Haramati LB, Schulman LL, Austin JHM. Lung nodules and masses after cardiac transplantation. Radiology 1993;188;491-497.
15. Barnes AJ, Denning DW. Aspergillus - significance as a pathogen. Rev Med Microbiol 1993;4:176-180.
16. Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis 1992;14:141-148.
17. Duthie R, Denning DW. Aspergillus fungemia. Two cases and review. Clin Infect Dis, 1995;20:598-605.
18. Martino P, Girmenia C, Micozzi A et al. Fungemia in patients with leukemia. Am J Med Sci 1993;306:225-232.
19. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Role of fibreoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1984;76:1027-1034.
20. Kahn FW, Jones JM, England DM et al. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518-523.
21. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Resp Med 1992;86:243-248.
22. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 1988;94:745-749.
23. Kramer MR, Denning DW, Marshall SE et al. Ulcerative tracheobronchitis following lung transplantation: a new form of invasive aspergillosis. Am Rev Resp Dis 1991;144:552-556.
24. Denning DW, Follansbee S, Scolaro M, Norris S, Edelstein D, Stevens DA. Pulmonary aspergillosis in AIDS. N Engl J Med 1991;324:654-662.
25. Lortholary O, Meyohas MC, Dupont B et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. Am J Med 1993;95:177-187.
26. Denning DW. The treatment of invasive aspergillosis. J Infect 1994;28 (suppl 1):25-33.
27. van 't Wout JW, Novakova I, Verhagen CAH, Fibbe WE, De Pauw BE, Van der Meer JWM. The efficacy of itraconazole against systemic fungal infection in neutropenic patients: a randomised comparative study with amphotericin B. J Infect 1991; 22:45-52.
28. De Beule K, De Doncker P, Cauwenbergh G et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 1988;31:476-485.
29. Kreisel W, Köchling G, Schilling CV et al. Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Mycoses 1991;34:385-394.
30. Jennings TS, Hardin TC. Treatment of aspergillosis with itraconazole. Ann Pharmacother 1993;27:1206-1211.
31. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990;23:607-614.
32. Denning DW, Lee JY, Hostetler JS et al. NIAID mycoses study group multicenter trial of oral itrazonazole therapy for invasive aspergillosis. Am J Med 1994;97:135-144.
33. Caillot D, Casasnovas O, Couaillier JF et al. Improvement of invasive pulmonary aspergillosis prognosis in neutropenic patients by using early CT-scan and itraconazole. Abstract J28, 35th ICAAC, San Francisco, 1995.
34. Sugar AM. Use of amphotericin B with azole antifungal drugs: What are we doing? Antimicrob Agents Chemother 1995;39:1907-1912.
35. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990;12:1147-1201.
36. Kibbler CC, Milkins SR, Bhamra A, Spiteri MA, Noone P, Prentice HG. Apparent pulmonary mycetoma following intensive aspergillosis in neutropenic patients. Thorax 1988;43:108-112.
37. Ribrag V, Dreyfus F, Venot A, Leblong V, Lanore JJ, Varet B. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. Leuk Lymph 1993;10:317-321.